162 related articles for article (PubMed ID: 15911704)
21. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion.
Stewart JM
Pediatr Res; 2000 Aug; 48(2):218-26. PubMed ID: 10926298
[TBL] [Abstract][Full Text] [Related]
22. Differences in cardiac autonomic function contributes to heart rate abnormalities in POTS and IST.
Corkal JC; Palamarchuk I; Kimpinski K
Auton Neurosci; 2014 Dec; 186():85-90. PubMed ID: 25277318
[TBL] [Abstract][Full Text] [Related]
23. Splanchnic Venous Compression Enhances the Effects of ß-Blockade in the Treatment of Postural Tachycardia Syndrome.
Smith EC; Diedrich A; Raj SR; Gamboa A; Shibao CA; Black BK; Peltier A; Paranjape SY; Biaggioni I; Okamoto LE
J Am Heart Assoc; 2020 Jul; 9(14):e016196. PubMed ID: 32673517
[TBL] [Abstract][Full Text] [Related]
24. Neurocirculatory abnormalities in chronic orthostatic intolerance.
Goldstein DS; Eldadah B; Holmes C; Pechnik S; Moak J; Sharabi Y
Circulation; 2005 Feb; 111(7):839-45. PubMed ID: 15699262
[TBL] [Abstract][Full Text] [Related]
25. Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
Nwazue VC; Arnold AC; Raj V; Black BK; Biaggioni I; Paranjape SY; Orozco C; Dupont WD; Robertson D; Raj SR
Clin Exp Pharmacol Physiol; 2014 May; 41(5):325-30. PubMed ID: 24606242
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects.
Nóbrega AC; dos Reis AF; Moraes RS; Bastos BG; Ferlin EL; Ribeiro JP
Clin Auton Res; 2001 Feb; 11(1):11-7. PubMed ID: 11503945
[TBL] [Abstract][Full Text] [Related]
27. Supine Parasympathetic Withdrawal and Upright Sympathetic Activation Underly Abnormalities of the Baroreflex in Postural Tachycardia Syndrome: Effects of Pyridostigmine and Digoxin.
Stewart JM; Warsy IA; Visintainer P; Terilli C; Medow MS
Hypertension; 2021 Apr; 77(4):1234-1244. PubMed ID: 33423527
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome.
Lewis I; Pairman J; Spickett G; Newton JL
J Intern Med; 2013 May; 273(5):501-10. PubMed ID: 23206180
[TBL] [Abstract][Full Text] [Related]
29. Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects.
Sant'anna ID; de Sousa EB; de Moraes AV; Loures DL; Mesquita ET; da Nóbrega AC
Clin Sci (Lond); 2003 Aug; 105(2):161-5. PubMed ID: 12627998
[TBL] [Abstract][Full Text] [Related]
30. Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease.
Castro RR; Serra SM; Porphirio G; Mendes FS; Oliveira LP; Nóbrega AC
Int J Cardiol; 2006 Feb; 107(1):138-9. PubMed ID: 16337518
[TBL] [Abstract][Full Text] [Related]
31. Acute hemodynamic effects of a selective serotonin reuptake inhibitor in postural tachycardia syndrome: a randomized, crossover trial.
Mar PL; Raj V; Black BK; Biaggioni I; Shibao CA; Paranjape SY; Dupont WD; Robertson D; Raj SR
J Psychopharmacol; 2014 Feb; 28(2):155-61. PubMed ID: 24227635
[TBL] [Abstract][Full Text] [Related]
32. Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure.
Serra SM; Costa RV; Teixeira De Castro RR; Xavier SS; Nóbrega AC
J Card Fail; 2009 Mar; 15(2):124-9. PubMed ID: 19254671
[TBL] [Abstract][Full Text] [Related]
33. A prospective 1-year study of postural tachycardia and the relationship to non-postural versus orthostatic symptoms.
Baker J; Kimpinski K
Physiol Behav; 2015 Aug; 147():227-32. PubMed ID: 25936824
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin in the treatment of postural orthostatic tachycardia syndrome.
Kanjwal K; Saeed B; Karabin B; Kanjwal Y; Sheikh M; Grubb BP
Am J Ther; 2012 Mar; 19(2):92-5. PubMed ID: 20838326
[TBL] [Abstract][Full Text] [Related]
35. Cholinesterase inhibition reduces arrhythmias in asymptomatic Chagas disease.
Castro RRT; Porphirio G; Xavier SS; Moraes RS; Ferlin EL; Ribeiro JP; da Nóbrega ACL
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28715142
[TBL] [Abstract][Full Text] [Related]
36. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats.
Soares PP; da Nóbrega AC; Ushizima MR; Irigoyen MC
Auton Neurosci; 2004 Jun; 113(1-2):24-31. PubMed ID: 15296792
[TBL] [Abstract][Full Text] [Related]
37. The relation between lower limb pooling and blood flow during orthostasis in the postural orthostatic tachycardia syndrome of adolescents.
Stewart JM; Weldon A
J Pediatr; 2001 Apr; 138(4):512-9. PubMed ID: 11295714
[TBL] [Abstract][Full Text] [Related]
38. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome.
Hoad A; Spickett G; Elliott J; Newton J
QJM; 2008 Dec; 101(12):961-5. PubMed ID: 18805903
[TBL] [Abstract][Full Text] [Related]
39. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders.
Shibao C; Arzubiaga C; Roberts LJ; Raj S; Black B; Harris P; Biaggioni I
Hypertension; 2005 Mar; 45(3):385-90. PubMed ID: 15710782
[TBL] [Abstract][Full Text] [Related]
40. Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes.
Dewland TA; Androne AS; Lee FA; Lampert RJ; Katz SD
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H86-92. PubMed ID: 17322413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
